AKT1 and neoplasm: Studies have demonstrated that liraglutide significantly impairs colorectal cancer cell migration, invasion, and proliferation by inhibiting the PI3K/Akt/mTOR signaling pathway, while concurrently promoting tumor cell apoptosis [77].